Rockefeller Capital Management L.P. Grows Position in HealthEquity, Inc. $HQY

Rockefeller Capital Management L.P. raised its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 61.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,491 shares of the company’s stock after acquiring an additional 5,541 shares during the period. Rockefeller Capital Management L.P.’s holdings in HealthEquity were worth $1,328,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Wasatch Advisors LP grew its holdings in shares of HealthEquity by 4.5% in the fourth quarter. Wasatch Advisors LP now owns 6,589,646 shares of the company’s stock valued at $603,677,000 after purchasing an additional 281,971 shares in the last quarter. Geode Capital Management LLC raised its stake in HealthEquity by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after purchasing an additional 5,671 shares in the last quarter. Westfield Capital Management Co. LP lifted its position in HealthEquity by 13.7% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after purchasing an additional 235,794 shares during the last quarter. William Blair Investment Management LLC bought a new position in HealthEquity during the fourth quarter valued at $169,956,000. Finally, AQR Capital Management LLC grew its stake in shares of HealthEquity by 59.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock worth $167,200,000 after buying an additional 656,820 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HQY. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and upped their target price for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Finally, Citizens Jmp lifted their target price on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $110.57.

Insider Activity

In related news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares in the company, valued at $8,202,690. The trade was a 7.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 13,081 shares of company stock valued at $1,193,000. 1.60% of the stock is currently owned by insiders.

HealthEquity Price Performance

HealthEquity stock opened at $92.29 on Thursday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $105.96. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $85.57 and a 200-day moving average price of $84.61. The firm has a market capitalization of $7.72 billion, a PE ratio of 34.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.